EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 8, 2013, Pages 1327-1335

  Stella, Giulia M ^a,b   Scabini, Roberta ^a   Inghilleri, Simona ^a   Cemmi, Francesca ^a   Corso, Simona ^c   Pozzi, Ernesto ^d   Morbini, Patrizia ^a   Valentini, Adele ^a   Dore, Roberto ^a   Ferrari, Simona ^a   Luisetti, Maurizio ^a   Zorzetto, Michele ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

EGFR; Kras; Lung cancer; Somatic mutations

Indexed keywords

GENOMIC DNA; K RAS PROTEIN; VASCULOTROPIN RECEPTOR;

ADULT; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTATION RATE; ONCOGENE; ONCOGENE K RAS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TISSUE CHARACTERIZATION; TUMOR CELL;

AGED; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84880922207     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1444-y     Document Type: Article

References (15)

1. Bardelli A, Parson DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300(5621):949
2. Chen CM, Chang JW, Cheung YC, Lin G, Hsieh JJ, Hsu T, Huang SE (2008) Computed tomography-guided core-needle biopsy specimens demonstrated epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Acta Radiol 49(9):991-994
3. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol 21:2237-2246
4. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Eng J Med 359(13):1367-1380
5. Kalikaki A, Koutsopoulos A, Trypaki M, Souglakos J, Stathopoulos E, Georgoulias V, Mavroudis D, Voutsina A (2008) Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Br J Cancer 99(6):923-929
6. Krause D, van Etten R (2005) Tyrosine kinases as targets for cancer therapy. N Eng J Med 353:172-187
7. Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760-774
8. Penzel R, Sers C, Chen Y, Lehmann-Muhlenhoff U, Merkelbach-Bruse S, Jung A, Kirchner T, Buttner R, Kreipe HH, Petersen I, Dietel M, Schirmacher P (2011) EGFR mutation detection in NSCLC - assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch 458(1):95-98
9. Pirker R, Herth FJ, Kerr KM, Filippits M, Taron M, Gandara D, Hirsh FR, Grunewald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Capuzzo F, Stahel R, European EGFR Workshop Group (2010) Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 5(10):1706-1713
10. Schmidt K, Oehl N, Wrba F, Pirker R, Pirker C, Filipits M (2009) EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Clin Cancer Res 15(14):4554-4560
11. Schuurbiers OC, Looijen-Salamon MG, Ligtenberg MJ, van der Heijedn HF (2010) A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol 5(10):1664-1667
12. Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA (2011) Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3(75):75ra26
13. Sharma SV, Bell DW, Settleman J, Haber DA (2007) Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7:169-181
14. Solomon S, Zakowski MF, Pao W, Thorton RH, Ladany M, Kris MG, Rush VW, Rizvi NA (2010) Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis. Am J Roentgenol 194(1):266-269
15. Stella GM, Luisetti M, Inghilleri S, Cemmi F, Scabini R, Zorzetto M, Pozzi E (2012) Targeting EGFR in non-small cell lung cancer: lessons, experiences, strategies. Respir Med 106(2):173-183